Horizon Kinetics Medical ETF Rating $27.63 -0.30 (-1.07%) Closing price 03:58 PM EasternExtended Trading$27.63 0.00 (0.00%) As of 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsRatingsTrendsBuy This Stock Horizon Kinetics Medical ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.MEDX Aggregate RatingModerate Buy 2.70Holdings in MEDX have an aggregate rating of Moderate Buy based on 438 analyst ratings issued in the past year covering 32 companies (88.5% of the portfolio).MEDX Aggregate Price Target$27.63High Prediction$27.63Average Prediction$27.63Low Prediction$27.63Holdings in MEDX have an aggregate price target of $27.63 and a range of $27.63 to $27.63 covering 32 companies (88.5% of the portfolio).MEDX Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy4 Buy rating(s)Moderate Buy16 Moderate Buy rating(s)Hold11 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Horizon Kinetics Medical ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 32 MEDX Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings16.67%LLYEli Lilly and Company$826.84-3.0%4.8361 of 5 stars2.85$1,009.72 22.1%20Analyst RevisionPositive News9.55%ABBVAbbVie$201.16-0.1%4.5468 of 5 stars2.92$211.45 5.1%25Positive News6.42%BMYBristol-Myers Squibb$59.180.0%3.9099 of 5 stars2.32$57.86 -2.2%19Options VolumePositive News6.29%AMGNAmgen$305.71-0.4%4.459 of 5 stars2.46$314.04 2.7%24Positive News5.54%AZNAstraZeneca$72.72-0.5%2.9417 of 5 stars3.10$89.75 23.4%10Positive News4.95%JNJJohnson & Johnson$161.64+0.4%4.5801 of 5 stars2.56$171.33 6.0%18Positive News4.83%ALNYAlnylam Pharmaceuticals$269.21-4.2%4.3104 of 5 stars2.76$312.30 16.0%25Analyst Upgrade4.72%ALKSAlkermes$33.69-0.6%4.6193 of 5 stars2.69$38.46 14.2%13News CoveragePositive News4.03%PFEPfizer$25.19-1.4%4.9891 of 5 stars2.63$31.92 26.7%16Analyst RevisionPositive News3.71%MRKMerck & Co., Inc.$88.06+0.2%5 of 5 stars2.65$117.12 33.0%232.81%REGNRegeneron Pharmaceuticals$640.14+0.9%4.8461 of 5 stars2.76$973.13 52.0%25Short Interest ↑Positive News2.62%GSKGSK$38.28-0.8%3.1831 of 5 stars2.60$43.25 13.0%102.60%BIIBBiogen$142.43+2.3%4.8687 of 5 stars2.43$213.33 49.8%30Positive News2.58%CRSPCRISPR Therapeutics$39.18-4.2%3.2918 of 5 stars2.48$73.11 86.6%212.43%IONSIonis Pharmaceuticals$31.49-2.4%4.3257 of 5 stars2.70$59.44 88.8%20Analyst Forecast1.32%BEAMBeam Therapeutics$21.91-5.6%3.4384 of 5 stars3.00$50.82 131.9%14Short Interest ↑Positive News0.92%REPLReplimune Group$10.40-2.7%3.8074 of 5 stars3.13$19.43 86.8%8Positive News0.86%HLNHaleon$10.05+0.0%2.6635 of 5 stars2.38$10.95 9.0%80.77%BCYCBicycle Therapeutics$8.73-1.4%1.9348 of 5 stars2.75$29.14 233.8%80.77%NTLAIntellia Therapeutics$8.31-4.8%4.4478 of 5 stars2.63$37.56 351.9%19Analyst Revision0.73%VNDAVanda Pharmaceuticals$4.77-0.8%4.3866 of 5 stars3.00$16.50 245.9%2Positive News0.65%LTRNLantern Pharma$3.65-5.2%0.8499 of 5 stars2.001Upcoming EarningsPositive News0.51%GALTGalectin Therapeutics$1.64-7.3%1.5177 of 5 stars2.00$11.00 570.7%1Upcoming EarningsPositive News0.51%TSVT2seventy bio$4.96+0.2%2.836 of 5 stars2.38$6.67 34.4%8Short Interest ↓0.49%SDZNYSandoz Group$41.69-4.2%1.5484 of 5 stars2.003Short Interest ↑Gap Down0.46%GEHCGE HealthCare Technologies$81.00-1.8%3.6896 of 5 stars2.77$98.75 21.9%13Positive News0.25%EDITEditas Medicine$1.27-2.3%4.0578 of 5 stars2.07$6.83 438.1%140.19%VTRSViatris$8.96+0.1%1.8214 of 5 stars1.75$10.50 17.2%4Short Interest ↑0.18%ALLOAllogene Therapeutics$1.57-1.9%3.0081 of 5 stars2.90$9.29 491.6%100.09%PACBPacific Biosciences of California$1.27-3.1%2.5162 of 5 stars2.54$2.46 93.6%13Analyst ForecastShort Interest ↓News Coverage0.05%MURAMural Oncology$1.33-9.5%2.5928 of 5 stars2.60$13.00 877.4%5Analyst DowngradeNews CoverageGap UpHigh Trading Volume0.04%BLUEbluebird bio$3.75-2.6%2.8359 of 5 stars2.25$51.00 1,260.0%8 This page (NASDAQ:MEDX) was last updated on 3/26/2025 by MarketBeat.com Staff From Our PartnersElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredThe Dirty Secret About Gold Mining Stocks...Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy sharehold...Golden Portfolio | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Horizon Kinetics Medical ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Horizon Kinetics Medical ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MEDX Stock Free MEDX Stock Alerts